There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
E. Kelly Hester, PharmD
Advertisement
Articles by E. Kelly Hester, PharmD
Advertisement
Latest Updated Articles
- Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
Published: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
2
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
3
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
4
DOOR Analysis Shows Antibiotic Matches Standard Therapy in Effectiveness
5
